S. David Kimball

TAXIS Pharmaceuticals, Inc develops antibiotics for the treatment of multidrug-resistant bacteria. The company was founded by Edmond J. LaVoie, Gregory G. Mario and Daniel S. Pilch in 2009 and is headquartered in Monmouth Junction, NJ.

Z53 Therapeutics LLC designs therapeutics to target tumors with p53 protein mutations. It develops zinc metallochaperones as drugs to reactivate the function of mutant p53 protein in cancer cells through restoration of p53 zinc binding and folding. The company was founded by Darren Carpizo and S. David Kimball and is headquartered in Cleveland, OH.

Part of Interspot, Inc., BMS, Inc. provides multimedia marketing services. The company is based in Portland, ME. BMS was acquired by Interspot, Inc. on February 25, 2000 for $1 million.

Lexicon, Inc. engages in the provision of construction management and engineering services. It offers construction management, fabrication, erection, mechanical installation, and plant maintenance for heavy industrial, commercial, and roadway projects, as well as golf course construction and management services. The company was founded by Thomas B. Schueck in 1968 and is headquartered in Little Rock, AR.

Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA.

Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ.